Vyaire - Third Monthly Fee Application (September 2024)
- Date
- 2024-10-31
Summary
Exhibit A (Time Detail) to a monthly fee application, filed October 31, 2024 as Doc 696-2 in Case 24-11217-BLS, the Chapter 11 cases of Vyaire Medical, Inc. It reproduces McDermott Will & Emery LLP invoice 3944611, dated 10/14/2024, for services to the Vyaire Medical Creditors' Committee. Daily time entries from September 2024 are grouped by task code, covering case administration, asset disposition, Committee meetings, fee applications, contested matters including a Rule 2004 motion and interrogatories, and plan and disclosure statement work. The timekeeper summary reports 415.20 total hours and $565,547.50 in fees, and a task code summary shows 185.40 hours for Plan and Disclosure Statement. The exhibit runs 21 pages.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Full text
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 1 of 21
EXHIBIT A
Time Detail
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 2 of 21
Invoice: 3944611 10/14/2024
Client: 124433
Vyaire Medical, Inc.
26125 N. Riverwoods Boulevard
Mettawa, IL 60045
For Services Rendered in Connection with:
Matter: 0013 Vyaire Medical Creditors' Committee Chapter 11 Cases
Task Date Name Hours Description
B110 09/04/24 N. Rainey 0.30 Review case docket and download material
pleadings (.2); communicate with MWE team
regarding docket update (.1).
B110 09/05/24 N. Rainey 0.30 Review docket and relevant pleadings (.2);
communicate with MWE team regarding updated
deadlines and key dates (.1).
B110 09/10/24 N. Rainey 0.20 Review docket and relevant pleadings (.1);
communicate with MWE team regarding updated
deadlines and key dates (.1).
B110 09/12/24 N. Rainey 0.30 Review docket and relevant pleadings (.2);
communicate with MWE team regarding updated
deadlines and key dates (.1).
B110 09/18/24 N. Rainey 0.30 Review case docket and download material
pleadings (.2); communicate with MWE team
regarding docket update (.1).
B110 09/19/24 N. Rainey 0.40 Review docket and relevant pleadings (.1);
communicate with MWE team regarding updated
deadlines and key dates (.3).
B110 09/24/24 K. Going 0.80 Call with BRG on case update (.8).
B110 09/24/24 N. Rainey 1.00 Correspond with K. Going re 8.30.24 hearing
transcript (.1); download and review August
monthly operation reports for 28 Debtor entities (.8);
circulate same to MWE team (.1).
B130 09/03/24 R. Trickey 0.60 Review and analyze Trudell and Zoll APAs re
causes of action transferred pursuant to sale (.5);
correspond with M. Kandestin re same (.1).
B130 09/17/24 M. Kandestin 0.30 Communications with C. Wurzelbacher re status of
schedules to TSAs (.1); communications with C.
Wurzelbacher re foreign entity issues re asset sales
(.1); communications with R. Zaidman re new
closing date for Trudell transaction (.1).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
1
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 3 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B130 09/18/24 W. Hadler 1.00 Correspondence with company counsel related to
closing conditions (.3); discuss closing conditions
with K. Going (.3); review asset purchase
agreements and analyze closing conditions (.4).
B130 09/19/24 K. Going 1.70 Calls and emails with BRG on sale closing issues
(1.7).
B130 09/20/24 K. Going 2.10 Calls and emails with BRG and creditors on admin
claims and TSA issues (2.1).
B130 09/25/24 K. Going 0.80 Call with Debtors regarding closing issues (.8).
B130 09/27/24 M. Kandestin 0.10 Communications with R. Zaidman re sale
transaction closing issues (.1).
B130 09/27/24 K. Going 2.20 Correspondence and calls regarding Zoll closing
with Debtors, BRG and creditors counsel (multiple
calls with each) (2.2).
B130 09/28/24 K. Going 1.00 Correspondence with Debtors, creditors and BRG on
Zoll sale closing issues (1.0).
B130 09/30/24 K. Going 2.50 Review information from Debtors on Zoll sale
amendments (1.8); discuss issues with BRG (.7).
B150 09/03/24 C. Wurzelbacher 1.10 Attend meeting with Committee re case status,
ongoing workstreams (.5); conference with BRG
team in preparation for same (.6).
B150 09/03/24 R. Trickey 1.80 Participate in meeting with BRG team to discuss
9.3.2024 Committee meeting (.6); participate in
Committee meeting (.6); draft minutes of 9.3.2024
Committee meeting (.6).
B150 09/03/24 D. Hurst 0.90 Prepare for and call with Committee and Committee
professionals re status of professional workstreams,
outcome of recent hearing, financial updates (.9).
B150 09/03/24 M. Kandestin 2.40 Communications with K. Newsome re Committee
meeting (.2); communications with R. Trickey re
agenda for same (.2); call with D. Azman re same
(.1); call with BRG team re preparation for
Committee meeting (.4); participate in Committee
meeting (.6); call with R. Zaidman re post-meeting
following up questions (.1); communications with R.
Trickey re same (.1); communications with Debtors
re same (.2); communications with D. Azman re
same (.1); review materials in connection with same
and communications with Committee re same (.3);
review minutes from September 3, 2024 Committee
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
2
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 4 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
meeting and communications with R. Trickey re
revisions to same (.1).
B150 09/03/24 D. Azman 2.80 Prepare for weekly Committee call (1.4); pre-call
with BRG (.5); participate in weekly Committee call
(.7); discuss same with M. Kandestin (.2).
B150 09/04/24 R. Trickey 0.10 Correspond with Committee re minutes for 9.3.2024
Committee meeting (.1).
B150 09/04/24 M. Kandestin 0.50 Communications with Debtors re Committee
concerns (.1); communications with Committee re
same and case updates (.2); communication with
BRG team re same (.1); communications with R.
Trickey re same (.1).
B150 09/08/24 R. Trickey 2.30 Draft presentation for 9.11.2024 Committee meeting
re plan and proposed revisions (2.3).
B150 09/09/24 M. Kandestin 0.90 Review Committee presentation materials re chapter
11 plan (.7); communications with C. Wurzelbacher
and R. Trickey re comments to same (.2).
B150 09/09/24 R. Trickey 1.10 Correspond with M. Kandestin re 9.11.2024
presentation to Committee (.2); revise same (.9).
B150 09/10/24 D. Hurst 0.80 Prepare for and call with Committee professionals re
status of professional workstreams, preparation for
upcoming call with Committee (.8).
B150 09/10/24 R. Trickey 1.30 Meet with BRG team for weekly meeting to discuss
case updates and Committee meeting (.7); prepare
materials for 9.11.2024 Committee meeting (.5);
teleconference with K. Newsome re same (.1).
B150 09/10/24 M. Kandestin 0.90 Call with BRG team re preparation for weekly
Committee call (.7); communications with R.
Trickey re Committee presentation materials, agenda
for Committee meeting (.2).
B150 09/10/24 D. Azman 1.90 Review materials for weekly Committee call (1.3);
prepare for same (.6).
B150 09/11/24 C. Wurzelbacher 1.50 Attend meeting with Committee re case status,
disclosure schedules, and plan (1.0); review meeting
minutes re same (.4); correspond with R. Trickey re
same (.1).
B150 09/11/24 M. Kandestin 1.60 Review investigation update materials for
Committee meeting (.1); communications with K.
Newsome, K. Schwam, and M. Gibson re comments
to same (.2); participate in weekly Committee call
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
3
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 5 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
(1.3).
B150 09/11/24 D. Hurst 1.60 Review and analyze Committee investigation update
presentation and DIP and liquidity report (.5);
prepare for and call with Committee and Committee
professionals re status of professional work streams,
including investigation (1.1).
B150 09/11/24 R. Trickey 2.80 Prepare for and participate in weekly Committee
meeting (2.1); draft minutes re 9.11.2024 Committee
meeting (.7).
B150 09/11/24 D. Azman 3.90 Continue to prepare for Committee weekly call
(1.0); participate in weekly Committee meeting
(1.1); discuss strategy re same with K. Going, M.
Kandestin, et al. (1.8).
B150 09/13/24 M. Kandestin 0.10 Communications with Committee member re sale
issues (.1).
B150 09/16/24 K. Going 1.30 Prepare response to Committee questions (.8);
internal discussions regarding investigation and plan
(.5).
B150 09/17/24 C. Wurzelbacher 0.50 Conference with BRG team in preparation for
Committee meeting (.5).
B150 09/17/24 R. Trickey 1.20 Participate in meeting with MWE and BRG teams re
9.18.2024 Committee meeting (1.1); correspond
with Committee re updated DIP budget (.1).
B150 09/17/24 M. Kandestin 1.30 Communications with K. Going re Committee
presentation materials (.2); call with MWE and BRG
teams re preparation for Committee call (1.1).
B150 09/17/24 K. Going 2.30 Participate in weekly prep meeting with BRG (1.3);
review and respond to questions from Committee
members (.5); internal discussions with Committee
requests (.5).
B150 09/18/24 K. Going 1.00 Review and respond to Committee inquiries (1.0).
B150 09/18/24 D. Hurst 0.80 Prepare for upcoming Committee meeting, including
review and analysis of presentation materials (.3);
attend portion of call with Committee and
Committee professional re status of professional
workstreams, financial reporting (.5).
B150 09/18/24 M. Kandestin 2.40 Call with BRG and MWE teams re preparation for
Committee call (.9); communications with R.
Trickey re agenda for Committee meeting,
presentation materials re same (.2); communications
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
4
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 6 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
with K. Newsome re preparation for Committee call,
updated investigation materials, and review same
(.3); participate in Committee call (partial
attendance) (.9); review draft minutes of September
18, 2024 Committee meeting and communications
with R. Trickey re same (.1).
B150 09/18/24 C. Wurzelbacher 0.20 Conference with MWE and BRG teams in
preparation for Committee meeting (.2).
B150 09/18/24 R. Trickey 2.90 Participate in call with BRG re Committee meeting
(.8); participate in weekly Committee meeting (1.1);
compile weekly minutes (1.0).
B150 09/22/24 R. Trickey 0.80 Draft creditor correspondence re sale orders and
contract assumption (.8).
B150 09/23/24 M. Kandestin 0.90 Review draft correspondence to unsecured creditor
and communications with R. Trickey re revisions to
same (.1); communications with K. Newsome re
investigation issues (.2); call with K. Newsome, K.
Schwam, and M. Gibson re same, disclosure
statement objection, next steps (.6).
B150 09/23/24 R. Trickey 0.20 Correspond with creditor re sale orders (.2).
B150 09/24/24 M. Kandestin 0.60 Call with BRG team re preparation for weekly
Committee call (.6).
B150 09/25/24 M. Kandestin 1.10 Participate in weekly Committee call (1.1).
B160 09/03/24 D. Hurst 1.10 Begin to review and revise McDermott August fee
application (1.1).
B160 09/12/24 D. Hurst 2.60 Review McDermott August time detail for privilege
and compliance with local rules (2.3); draft multiple
correspondence to D. Galfus re BRG June-July fee
application (.2); draft correspondence to N. Rainey
re same (.1).
B160 09/13/24 D. Hurst 0.70 Review BRG first monthly fee application in
preparation for filing (.3); draft multiple
correspondence to D. Galfus, M. Haverkamp re
same (.2); review and revise notice of fee
application (.1); draft correspondence to N. Rainey
re filing of same (.1).
B160 09/13/24 N. Rainey 1.10 Review docket and prepare CNO re MWE's first
monthly fee application (.3); correspond with D.
Hurst re same (.1); finalize and electronically file
BRG's first monthly fee application (.3); correspond
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
5
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 7 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
with D. Hurst re same (.2); coordinate with Reliable
regarding mail service of same along with the
preparation and filing of their affidavit of service
regarding service (.2).
B160 09/14/24 D. Hurst 3.60 Review and revise certification of no objection re
McDermott first monthly fee application (.1); draft
correspondence to N. Rainey re filing of same (.1);
review revised McDermott August time detail for
privilege and compliance with local rules (1.6); draft
correspondence to R. Trickey re preparation of rider
for fee application (.1); review and revise
McDermott August fee application (1.7).
B160 09/16/24 N. Rainey 0.30 Finalize and electronically file CNO re MWE's first
monthly fee application (.2); correspond with D.
Hurst re same (.1).
B160 09/18/24 R. Trickey 1.50 Draft rider for second MWE fee application (1.4);
correspond with D. Hurst re same (.1).
B160 09/28/24 D. Hurst 2.30 Review and revise McDermott August fee
application (2.2); draft correspondence to D. Azman,
K. Going re same (.1).
B190 09/03/24 K. Newsome 1.00 Prepare investigation update (.3); conference with
Committee re matter updates (.7).
B190 09/05/24 M. Gibson 0.40 Analyze documents to determine tenure of
independent directors (.4).
B190 09/06/24 M. Kandestin 0.50 Call with K. Newsome re investigation issues (.5).
B190 09/09/24 M. Kandestin 0.20 Communications with K. Newsome re investigation
issues (.1); communications with D. Azman and K.
Going re same (.1).
B190 09/09/24 K. Newsome 1.30 Review and analyze investigation analysis (.8);
correspond with internal team regarding Debtor's
documents (.5).
B190 09/10/24 M. Gibson 0.20 Confer with K. Newsome and K. Schwam on Rule
2004 motion and discovery requests (.2).
B190 09/10/24 M. Kandestin 1.10 Call with K. Newsome re investigation issues (.3);
communications with R. Trickey re Debtors'
litigation assets (.1); review BRG's comments to
litigation summary (.1); communications with BRG
team re litigation assets (.1); communications with
K. Newsome re formulation of interrogatories to
Apax and the Debtors, 2004 motion (.5).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
6
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 8 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B190 09/10/24 K. Schwam 3.30 Review previous filings and public disclosures, and
draft Rule 2004 motion (3.1); confer with K.
Newsome and M. Gibson regarding matter status
(.2).
B190 09/10/24 K. Newsome 4.70 Conferences with M. Kandestin, K. Schwam, R.
Trickey, and M. Gibson re plan discovery (1.3);
conference with BRG re upcoming Committee
meeting (.7); prepare document requests and
interrogatories (2.7).
B190 09/11/24 M. Kandestin 1.40 Call with K. Newsome re Rule 2004 motion (.4);
revise draft interrogatories (.7); communications
with K. Newsome re same (.1); review updated
version of interrogatories and communications with
K. Newsome re additional comments to same (.1);
communications with R. Orloff, K. Newsome, and
R. Trickey re new assets, liens on same, next steps
(.1).
B190 09/11/24 M. Gibson 1.60 Analyze statement of financial affairs filed on the
docket to identify total payments to insiders (1.6).
B190 09/11/24 R. Trickey 0.60 Correspond with investigation team and BRG team
re insider payments (.1); review and analyze
schedules and SOFAs re same (.5).
B190 09/11/24 K. Schwam 3.00 Review public disclosures and produced documents,
and draft Rule 2004 motion (2.6); confer with K.
Newsome regarding outstanding document
production and Rule 2004 motion (.4).
B190 09/11/24 K. Newsome 5.30 Conference with M. Kandestin re investigation
strategy (.4); prepare investigation updates (.8); draft
interrogatories and document requests to Debtor
(1.1); conference with Committee (1.3); review and
analyze documents (1.0); correspond with internal
team re objections to plan (.7).
B190 09/12/24 M. Gibson 0.70 Analyze documents to identify payments to non-
Debtor insiders (.7).
B190 09/12/24 M. Kandestin 0.30 Communications with K. Going re recently
discovered assets (.1); call with K. Newsome re
interrogatories and 2004 requests (.2).
B190 09/12/24 K. Schwam 2.20 Confer with K. Newsome regarding matter (.5);
revise Rule 2004 motion and review Rule 2004 case
law (1.7).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
7
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 9 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B190 09/12/24 K. Newsome 3.30 Prepare draft 2004 motion (1.0); confer with M.
Kandestin and K. Schwam re same (1.2); confer
with K. Schwam and M. Gibson re document
requests (.7); confer with M. Kandestin re discovery
(.4).
B190 09/13/24 M. Kandestin 0.10 Communications with K. Newsome re discovery
issues (.1).
B190 09/13/24 K. Newsome 1.20 Prepare and serve discovery requests on Debtors
(.8); communicate with Committee re discovery
requests (.3); communicate with Debtors re same
(.1).
B190 09/16/24 J. Haims 1.50 Review and analyze Cole Schotz claim investigation
presentation for Committee and declaration in
support of first day motions, and correspondence
regarding same (1.5).
B190 09/16/24 M. Kandestin 0.10 Communications with K. Newsome re investigation
issues (.1).
B190 09/16/24 K. Schwam 1.10 Revise Rule 2004 motion (1.1).
B190 09/16/24 K. Newsome 1.30 Continue to prepare draft 2004 motion (1.3).
B190 09/16/24 E. Shereff 0.50 Meet with K. Newsome re litigation matters for
introductory meeting (.5).
B190 09/17/24 M. Gibson 0.60 Analyze scheduling orders for filing deadlines (.1);
confer internally on document review strategy (.5).
B190 09/17/24 D. Valentino 1.00 Load incoming production set, and update dtSearch,
production fields and search term reports (1.0).
B190 09/17/24 J. Haims 2.00 Continue to review Cole Schotz claim investigation
presentation for Committee, declaration in support
of first day motions, and chapter 11 plan (1.5);
correspondence regarding same and strategy (.5).
B190 09/17/24 M. Kandestin 0.20 Communications with K. Newsome, K. Schwam,
and M. Gibson re discovery, investigation issues
(.2).
B190 09/17/24 E. Kwon 0.70 Coordinate preparing new custodial documents
production in the discovery document repository for
case development review (.7).
B190 09/17/24 K. Schwam 3.00 Confer with M. Gibson and K. Newsome regarding
document review and matter (.5); confer with
discovery team regarding latest document
production (.3); review and analyze produced
documents, and test search terms in database (2.2).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
8
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 10 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B190 09/17/24 K. Newsome 1.50 Confer with Cole Schotz and internal team re
production (.4); conference with internal team and
BRG re strategy (1.1).
B190 09/17/24 E. Shereff 7.50 Review docket on Pacer to pull key documents
(2.6); analyze and circulate key filed documents in
case to-date (3.1); research law on applicable
potential claims (1.8).
B190 09/18/24 M. Gibson 1.90 Confer internally on document review strategy (.5);
analyze documents to corroborate causes of action
(1.4).
B190 09/18/24 J. Haims 0.50 Review investigation related documents and
correspondence regarding same and strategy (.5).
B190 09/18/24 E. Kwon 0.60 Identify non-relevant documents in the VY
production documents to reduce review volume (.6).
B190 09/18/24 K. Schwam 4.70 Review and analyze production of email data, and
draft search terms to review same (2.7); confer with
K. Newsome and M. Gibson regarding matter and
document review items (.5); revise investigation
update deck for the Committee (.3); review and
analyze information related to email regarding going
concern analysis (1.2).
B190 09/18/24 K. Newsome 5.20 Conference with internal team re investigation and
document review (.7); conference with BRG re
strategy (.5); prepare for and participate in
conference with Committee re strategy (1.8);
prepare investigative plan and correspond with
internal team re same (2.2).
B190 09/18/24 E. Shereff 7.00 Annotate and analyze chapter 11 bankruptcy plan
for fact sheet report (2.3); annotate and analyze Cole
Schotz investigation document for fact sheet report
(2.9); brainstorm potential fact witnesses based on
key players (1.8).
B190 09/19/24 J. Haims 1.00 Continue to review investigation related documents
and correspondence regarding same and strategy
(1.0).
B190 09/19/24 M. Kandestin 0.30 Review proposed search terms re custodial
documents and communications with K. Newsome
re additions to same (.1); review certain documents
produced (.2).
B190 09/19/24 E. Kwon 0.50 Continue to identify fraud related documents in the
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
9
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 11 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
VY production documents for case development
review (.3); prepare report of same (.2).
B190 09/19/24 K. Newsome 0.50 Correspond with internal team re document review
(.5).
B190 09/19/24 K. Schwam 3.60 Revise and test search terms (.7); review, analyze,
and summarize produced documents relevant to
flagged issues (2.9).
B190 09/20/24 M. Gibson 0.30 Analyze documents to corroborate causes of action
(.3).
B190 09/20/24 M. Kandestin 0.20 Communications with K. Schwam and R. Trickey re
investigation issues (.2).
B190 09/20/24 K. Schwam 5.00 Locate specific governing documents from
document production (.2); review and analyze
documents related to legal representation of Vyaire
during specific transactions (1.2); review, analyze,
and summarize produced custodial documents
related to specific transactions (3.2); review fraud
search term results (.4).
B190 09/20/24 E. Shereff 7.50 Annotate day one motions declaration for initial fact
sheet report (2.8); contemplate potential questions,
missing information and potential avenues towards
claims based on existing filings and work product
(1.9); background reading and research to
understand the facts of the case and applicable laws
(2.8).
B190 09/20/24 K. Newsome 1.00 Correspond and confer with internal team regarding
document review searches and strategy (1.0).
B190 09/23/24 M. Gibson 1.00 Analyze documents to corroborate causes of action
(.3); confer internally on document review strategy
(.7).
B190 09/23/24 K. Newsome 4.20 Conference with internal team re investigation
strategy and findings (.5); conference with M.
Kandestin re matter updates (.2): review and analyze
documents (2.0); correspond with internal team and
BRG re investigative findings (1.5).
B190 09/23/24 J. Haims 0.30 Continue to review investigation related documents
and correspondence regarding same and strategy
(.3).
B190 09/23/24 K. Schwam 6.60 Confer with M. Kandestin, K. Newsome, and M.
Gibson regarding status of matter and document
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
10
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 12 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
review (.6); review and analyze production for
relevant issues (3.4); summarize document review
findings to date (2.4); email with discovery
management team regarding search term reports (.2).
B190 09/23/24 E. Kwon 0.50 Continue to identify fraud related documents in the
VY production documents for case development
review (.3); continue to prepare report of same (.2).
B190 09/24/24 J. Haims 0.50 Continue to review investigation related documents
and correspondence regarding same and strategy
(.5).
B190 09/24/24 M. Gibson 3.90 Analyze documents to corroborate causes of action
(2.9); analyze responses and objections to latest
requests for production and interrogatories, and draft
high-level summary (1.0).
B190 09/24/24 K. Newsome 2.40 Teleconference with internal team and BRG re
developments and investigation (.6); correspond
with M. Kandestin and BRG re investigation (.3);
review and analyze documents (1.5).
B190 09/24/24 E. Shereff 7.50 Revise fact sheet report (2.8); outline and draft fact
sheet report (3.1); edit chart for organizational
structure, key dates and key players for fact sheet
report (1.6).
B190 09/24/24 E. Kwon 0.20 Continue to identify fraud related documents in the
VY production documents for case development
review (.1); prepare report of same (.1).
B190 09/24/24 K. Schwam 3.50 Confer with document management regarding
search terms and hits (.3); review, analyze, and
summarize produced documents related to identified
issues (2.9); review Debtor's objections and
responses to interrogatories and document requests
(.3).
B190 09/25/24 M. Gibson 1.80 Confer internally concerning Debtors responses to
interrogatories (.5); analyze documents to
corroborate causes of action and document findings
learned (.8); confer with M. Kandestin, K.
Newsome, and K. Schwam on investigation findings
(.5).
B190 09/25/24 J. Haims 0.50 Continue to review investigation related documents
and correspondence regarding same and strategy
(.5).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
11
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 13 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B190 09/25/24 M. Kandestin 0.60 Call with K. Newsome, K. Schwam, and M. Gibson
re Debtors' responses to interrogatories, next steps,
Committee meeting (.5); communications with K.
Newsome re next steps (.1).
B190 09/25/24 K. Schwam 3.00 Confer with team regarding Debtor's responses and
objections to interrogatories and document requests
(.6); review and analyze produced documents (2.4).
B190 09/25/24 K. Newsome 4.00 Prepare objections to plan (.8); teleconference with
M. Kandestin, K. Schwam, and M. Gibson re
Debtors responses and objections (.5); correspond
with Cole Schotz re same (.2); confer with Cole
Schotz re investigation presentation (.3); prepare
inquiries to Debtors (.6); participate in Committee
meeting (1.1); correspond with M. Gibson re
document analysis (.5).
B190 09/26/24 M. Kandestin 0.40 Conference with K. Newsome re investigation issues
(.4).
B190 09/26/24 K. Newsome 1.10 Correspond and confer with Cole Schotz re
investigation (1.1).
B190 09/26/24 K. Schwam 2.90 Continue to review, analyze, and summarize
produced documents (2.9).
B190 09/27/24 J. Haims 0.50 Continue to review investigation related documents
and correspondence regarding same and strategy
(.5).
B190 09/27/24 M. Kandestin 0.20 Call with K. Newsome re investigation issues (.2).
B190 09/27/24 K. Schwam 2.80 Continue to review, analyze, and summarize
produced documents (2.8).
B190 09/30/24 J. Haims 0.50 Continue to review investigation related documents
and correspondence regarding same and strategy
(.5).
B190 09/30/24 K. Newsome 0.50 Confer with K. Schwam re investigation plan (.5).
B190 09/30/24 M. Gibson 4.90 Analyze documents to corroborate causes of action
and document findings learned (4.9).
B190 09/30/24 K. Schwam 4.60 Continue to review, analyze and summarize
produced documents (2.7); draft summary of
consolidated investigation findings (1.1); review
Board meeting minutes and investigative interview
notes, and add to document review summary (.8).
B230 09/06/24 D. Hurst 0.20 Review and analyze variance reporting for period
ending August 30, 2024 (.2).
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
12
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 14 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
B230 09/12/24 R. Orloff 0.40 Attend to lien priority issues re sale assets (.4).
B230 09/14/24 D. Hurst 0.20 Review and analyze variance reporting for period
ending September 6, 2024 (.2).
B320 09/04/24 M. Kandestin 2.60 Review draft chapter 11 plan (2.5); communications
with D. Azman re same (.1).
B320 09/05/24 D. Hurst 3.30 Review and analyze draft plan (2.1); review and
analyze draft disclosure statement (1.2).
B320 09/05/24 M. Kandestin 10.10 Continue to review draft chapter 11 plan (3.0);
review draft disclosure statement (2.3);
communications with R. Trickey re research re plan
(.2); review same (.3); communications with BRG
team re draft chapter 11 plan (.3); revise chapter 11
plan (3.9); communications with MWE and BRG
teams re same (.1).
B320 09/05/24 R. Trickey 2.20 Research issues re plan structure vis-à-vis releases
(1.2); review and analyze APA and sale orders re
releases and related matters (.8); correspond with M.
Kandestin re same (.2).
B320 09/05/24 D. Azman 3.20 Review and revise plan and disclosure statement
(3.2).
B320 09/06/24 D. Azman 2.50 Review and revise plan and disclosure statement
(2.5).
B320 09/06/24 R. Trickey 2.00 Review and analyze plan and MWE comments to
same (2.0).
B320 09/06/24 M. Kandestin 1.20 Call with D. Azman re revisions to chapter 11 plan
(.2); call with R. Zaidman re same (.2); further
revise chapter 11 plan (.6); communications with
MWE team re same (.1); communications with
Debtors re same (.1).
B320 09/06/24 K. Schwam 0.50 Review and analyze proposed plan (.5).
B320 09/07/24 M. Kandestin 0.10 Communications with C. Wurzelbacher and R.
Trickey re draft solicitation procedures motion (.1).
B320 09/07/24 C. Wurzelbacher 0.20 Correspond with M. Kandestin, R. Trickey re
disclosure statement motion (.2).
B320 09/08/24 R. Trickey 2.10 Review and provide comments on disclosure
statement motion and ancillary documents (1.9);
correspond with C. Wurzelbacher re same (.2).
B320 09/09/24 D. Hurst 0.30 Review and analyze proposed revisions to plan (.3).
B320 09/09/24 C. Wurzelbacher 2.20 Review and revise disclosure statement motion and
exhibits (1.4); correspond with R. Trickey re same
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
13
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 15 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
(.3); review and analyze plan re same (.5).
B320 09/09/24 M. Kandestin 3.00 Communications with D. Azman and K. Going re
comments to chapter 11 plan (.1); communications
with R. Trickey re Committee presentation re same
(.1); prepare for call with Debtors re Committee's
plan comments (.6); call with D. Azman and K.
Going re same (.5); call with Debtors re same (.3);
call with K. Going re same (.2); review lenders'
comments to plan (.2); communications with MWE
and BRG teams re same (.1); review markup of
solicitation procedures motion and exhibits (.6);
communications with R. Trickey re additional
changes to same (.2); communications with C.
Wurzelbacher and R. Trickey re objection to
disclosure statement (.1).
B320 09/09/24 R. Trickey 2.00 Participate in conference with K&E team re
preliminary plan comments (.2); revise comments to
disclosure statement motion and ancillary materials
(1.7); correspond with K&E team re comments to
disclosure statement motion and ancillary
documents (.1).
B320 09/09/24 K. Going 2.40 Review Debtors plan draft (1.4); internal discussion
regarding same (.4); call with Debtors on plan (.6).
B320 09/09/24 D. Azman 2.30 Review and revise plan and disclosure statement
(2.3).
B320 09/10/24 C. Wurzelbacher 3.30 Research re plan releases (2.1); draft summary of
same (.9); correspond with K. Going, MWE team re
same (.3).
B320 09/10/24 M. Kandestin 1.00 Review updated chapter 11 plan (.6); call with R.
Zaidman re chapter 11 plan (.1); communications
with C. Wurzelbacher and R. Trickey re objection to
confirmation (.1); communications with D. Azman
and K. Going re updated version of chapter 11 plan
(.1); communications with B. Hackman re
confirmation timeline (.1).
B320 09/10/24 K. Going 3.70 Continue to review and revise plan (2.4); call with
lenders counsel re same(.5); internal discussion
regarding plan (.8).
B320 09/12/24 C. Wurzelbacher 2.60 Review and analyze plan, disclosure statement, and
DS motion (1.0); analyze issues re same (.5); draft
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
14
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 16 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
outline of objection re same (.9); correspond with R.
Trickey re same (.2).
B320 09/12/24 D. Hurst 1.70 Review and analyze solicitation procedures motion
(1.4); review and analyze Debtors’ motion to extend
plan exclusivity periods (.3).
B320 09/12/24 M. Kandestin 0.50 Communications with R. Trickey re solicitation
procedures motion, objection to disclosure statement
and plan (.1); review redline of as-filed version of
disclosure statement (.4).
B320 09/12/24 R. Trickey 0.70 Review and analyze as-filed disclosure statement
(.4); draft issues list re same (.3).
B320 09/12/24 K. Going 2.60 Analyze plan terms and Committee proposed
revisions (1.8); review memo on prepetition
unencumbered assets (.5); internal discussion
regarding same (.3).
B320 09/13/24 R. Trickey 1.90 Teleconference with C. Wurzelbacher re disclosure
statement objection (.1); draft issues list re
disclosure statement (1.0); draft disclosure statement
objection (.8).
B320 09/13/24 C. Wurzelbacher 2.60 Draft objection to disclosure statement motion (1.3);
review background documentation re same (.7);
research re same (.3); correspond with R. Trickey re
same (.3).
B320 09/14/24 R. Trickey 5.20 Draft objection to adequacy of disclosure statement
(5.2).
B320 09/14/24 M. Kandestin 1.00 Review outline of objection to disclosure statement
(.3); review plan re same (.2); provide comments to
same (.5).
B320 09/14/24 C. Wurzelbacher 2.20 Continue to draft objection to disclosure statement
motion (1.4); correspond with R. Trickey re same
(.2); review background materials re same (.6).
B320 09/15/24 C. Wurzelbacher 1.00 Continue to draft objection to disclosure statement
motion (.6); continue to review background
materials re same (.4).
B320 09/16/24 C. Wurzelbacher 3.50 Revise objection to disclosure statement (2.6);
review background documentation re same (.9).
B320 09/17/24 C. Wurzelbacher 3.20 Continue to revise objection to disclosure statement
(2.5); continue to review background materials re
same (.7).
B320 09/18/24 K. Going 2.40 Review analysis and work on formulating strategy
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
15
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 17 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
for plan and exit (1.8); correspondence with BRG
regarding same (.6).
B320 09/18/24 D. Hurst 0.50 Review and analyze liquidation analysis (.3); call
with K. Going re plan issue (.2).
B320 09/18/24 M. Kandestin 1.00 Review draft disclosure statement objection (1.0).
B320 09/19/24 M. Kandestin 3.40 Communications with R. Trickey re disclosure
statement objection (.1); continue to review draft
disclosure statement objection (2.4); compile list of
comments to same (.7); communications with C.
Wurzelbacher and R. Trickey re same (.2).
B320 09/19/24 R. Trickey 1.80 Research issues re liquidating plans and absolute
priority rule (1.7); teleconference with C.
Wurzelbacher re same (.1).
B320 09/19/24 C. Wurzelbacher 5.50 Continue to revise objection to disclosure statement
(2.4); research re same (1.4); continue to review
background documentation re same (1.4);
correspond with R. Trickey re same (.3).
B320 09/20/24 R. Trickey 8.40 Research and analyze issues re liquidating plans and
releases (1.3); correspond with C. Wurzelbacher and
M. Kandestin re disclosure statement objection (.3);
draft same (6.8).
B320 09/20/24 C. Wurzelbacher 3.60 Review and revise objection to disclosure statement
(2.2); continue to review background documentation
re same (1.4).
B320 09/20/24 K. Going 2.00 Continue to review investigation insights (1.6);
internal discussion with team (.4).
B320 09/21/24 C. Wurzelbacher 1.20 Continue to review and revise objection to DS
motion (.5); correspond with M. Kandestin re same
(.2); review Zoll and Trudell APAs (.4); correspond
with K. Going re same (.1).
B320 09/21/24 M. Kandestin 2.00 Review revised objection to disclosure statement
(1.9); communications with C. Wurzelbacher re
same (.1).
B320 09/22/24 M. Kandestin 7.90 Revise draft disclosure statement objection (7.9).
B320 09/23/24 K. Going 1.10 Call with Debtors counsel (.3); review DS objection
(.8).
B320 09/23/24 M. Kandestin 4.60 Continue to revise disclosure statement objection
(4.4); communications with C. Wurzelbacher re
motion to exceed page limits re disclosure statement
objection (.1); communications with C.
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
16
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 18 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
Wurzelbacher, K. Newsome re additional comments
to same (.1).
B320 09/23/24 C. Wurzelbacher 6.50 Continue to revise objection to disclosure statement
motion (3.2); continue to review background
documentation re same (1.9); research re same (1.0);
correspond with MWE team re same (.4).
B320 09/24/24 C. Wurzelbacher 9.10 Continue to review and revise disclosure statement
objection (2.6); continue to review background
documentation re same (1.1); correspond with M.
Kandestin re same (.4); review and revise plan (1.4);
conference with K. Going, MWE team re same (.6);
revise disclosure statement re same (2.2); research re
same (.4); correspond with M. Kandestin, MWE
team re same (.4).
B320 09/24/24 K. Going 5.30 Call with Kirkland on global resolution and cure,
sale closing issues (.8); calls with BRG on same
(1.3); review and comment on DS comments and
plan objection (3.2).
B320 09/24/24 M. Kandestin 4.40 Continue to revise disclosure statement objection
(1.8); communications with MWE and BRG teams
re same (.1); review additional materials re
investigation in connection with disclosure
statement objection (.2); research re issues related to
disclosure statement objection (.1); communications
with K. Going and C. Wurzelbacher re markups of
plan and disclosure statement (.2); review draft
Committee letter for inclusion in solicitation
materials (.3); review markup of plan (.3); revise
chapter 11 plan (1.0); communications with BRG re
information for disclosure statement objection (.1);
revise Committee solicitation letter (.2); call with
UST's office re plan and disclosure statement (.1).
B320 09/25/24 C. Wurzelbacher 6.10 Continue to review and revise disclosure statement
(2.9); continue to review background documentation
re same (.7); research re same (.5); continue to
review and revise objection to disclosure statement
(1.7); correspond with M. Kandestin, MWE team re
same (.3).
B320 09/25/24 M. Kandestin 6.60 Review markup of disclosure statement (.4);
communications with C. Wurzelbacher re additional
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
17
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 19 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
revisions to same, research re same (.4);
communications with K. Newsome re disclosure
statement objection (.1); communications with K.
Going re disclosure statement, objection to same
(.3); review current draft of disclosure statement
objection (2.6); revise same (2.1); review additional
revisions to disclosure statement objection (.1);
communications with C. Wurzelbacher re same (.1);
communications with C. Wurzelbacher re revisions
to disclosure statement (.1); review same (.3);
communications with C. Wurzelbacher, K. Going re
additional revisions to same (.1).
B320 09/25/24 K. Going 2.20 Review and revise DS objection (2.2).
B320 09/26/24 C. Wurzelbacher 3.70 Continue to review and revise objection to
disclosure statement (1.5); continue to review and
revise disclosure statement (1.7); conference with K.
Going, M. Kandestin re same (.5).
B320 09/26/24 D. Hurst 0.20 Meeting with K. Going re release issues (.2).
B320 09/26/24 M. Kandestin 6.10 Call with K. Going, D. Galfus, and R. Zaidman re
plan and disclosure statement issues (1.1); continue
to review disclosure statement objection (1.4);
communications with C. Wurzelbacher re same (.1);
prepare insert for disclosure statement (.2);
communications with K. Going re same (.1); revise
disclosure statement markup (1.0); communications
with K. Going re same (.2); conference with K.
Going and C. Wurzelbacher re disclosure statement
markup (.5); revise disclosure statement objection
(1.4); communications with K. Going and C.
Wurzelbacher re same (.1).
B320 09/27/24 C. Wurzelbacher 2.30 Continue to revise objection to disclosure statement
(1.1); continue to review background documentation
re same (.4); correspond with K. Going, MWE team
re same (.5); correspond with MWE team re
reservation of rights (.3).
B320 09/27/24 M. Kandestin 2.30 Review scaled back disclosure statement objection
(.2); revise same (.6); communications with C.
Wurzelbacher re additional comments to same (.2);
review updated version of same (.2);
communications with C. Wurzelbacher re comments
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
18
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 20 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Task Date Name Hours Description
to preliminary statement for same (.1); call with U.S.
Trustee re disclosure statement issues (.2);
communications with D. Azman and K. Going re
same (.1); communications with C. Wurzelbacher re
current version of disclosure statement objection
(.1); review reservation of rights re disclosure
statement (.2); communications with K. Going and
C. Wurzelbacher re same (.2); communications with
N. Rainey re same (.1); finalize same for filing (.1).
B320 09/27/24 K. Going 2.00 Review and revise Committee objection to
reservation of rights (1.3); update Committee
regarding same (.7).
B320 09/30/24 C. Wurzelbacher 2.50 Review and revise DS and plan (1.2); draft summary
re same (1.0); correspond with M. Kandestin, MWE
team re same (.3).
B320 09/30/24 M. Kandestin 1.80 Review redlines of plan documents (1.4);
communications with C. Wurzelbacher re same (.3);
communications with K. Going re same (.1).
Total Hours 415.20
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
19
Case 24-11217-BLS Doc 696-2 Filed 10/31/24 Page 21 of 21
Vyaire Medical, Inc. Client: 124433
Invoice: 3944611
Invoice Date: 10/14/2024
Timekeeper Summary
Name Hours Rate Amount
D. Azman 16.60 1,650.00 27,390.00
M. Gibson 17.30 805.00 13,926.50
K. Going 39.40 1,750.00 68,950.00
W. Hadler 1.00 1,575.00 1,575.00
J. Haims 7.30 1,830.00 13,359.00
D. Hurst 20.80 1,750.00 36,400.00
M. Kandestin 78.30 1,650.00 129,195.00
E. Kwon 2.50 570.00 1,425.00
K. Newsome 38.50 1,525.00 58,712.50
R. Orloff 0.40 1,525.00 610.00
N. Rainey 4.20 500.00 2,100.00
K. Schwam 49.80 1,200.00 59,760.00
E. Shereff 30.00 1,040.00 31,200.00
R. Trickey 43.50 925.00 40,237.50
D. Valentino 1.00 280.00 280.00
C. Wurzelbacher 64.60 1,245.00 80,427.00
Totals 415.20 $565,547.50
Task Code Summary
Task Code Description Hours Amount
B110 Case Administration 3.60 2,800.00
B130 Asset Disposition 12.30 20,815.00
B150 Mtgs/Communications w/Creditor 47.80 67,891.00
B160 Fee/Employment Applications 13.20 20,112.50
B190 Other Contested Matters 152.10 187,858.00
B230 Financing/Cash Collections 0.80 1,310.00
B320 Plan and Disclosure Statement 185.40 264,761.00
415.20 565,547.50
One Vanderbilt Avenue New York, NY 10017-3852 Tel +1 212 547 5400
US practice conducted through McDermott Will & Emery LLP.
20
File and source
- File
- gov.uscourts.deb.193283.696.2.pdf
- Size
- 504,685 bytes
- SHA-256
- 81c8d3584ec03ed43af4621dfce34acdafb27be5589f230c5b26129f9e3a43d5
- Original
- PACER (login required)